Molina Healthcare, Inc (NYSE:MOH – Get Free Report) Director Richard Schapiro sold 782 shares of the firm’s stock in a transaction on Tuesday, November 10th. The stock was sold at an average price of $203.94, for a total value of $159,481.08. Following the completion of the transaction, the director directly owned 11,833 shares of the company’s stock, valued at approximately $2,413,222.02. This trade represents a 6.20% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link.
Molina Healthcare Stock Performance
MOH traded down $0.48 during trading on Friday, reaching $209.37. 362,848 shares of the company’s stock were exchanged, compared to its average volume of 997,807. Molina Healthcare, Inc has a fifty-two week low of $121.06 and a fifty-two week high of $244.89. The company has a quick ratio of 1.69, a current ratio of 1.69 and a debt-to-equity ratio of 0.95. The business has a 50 day moving average price of $202.56 and a 200 day moving average price of $185.69. The company has a market capitalization of $10.93 billion, a P/E ratio of -218.09, a PEG ratio of 12.38 and a beta of 0.75.
Molina Healthcare (NYSE:MOH – Get Free Report) last announced its quarterly earnings results on Wednesday, October 21st. The company reported $0.89 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.79 by $0.10. Molina Healthcare had a negative net margin of 0.11% and a positive return on equity of 2.50%. The firm had revenue of $11.08 billion for the quarter, compared to analyst estimates of $10.86 billion. During the same quarter in the previous year, the firm posted $1.84 EPS. The business’s revenue for the quarter was down 3.4% on a year-over-year basis. As a group, analysts predict that Molina Healthcare, Inc will post 5.30 earnings per share for the current fiscal year.
More Molina Healthcare News
These are some of the MOH news items that stood out recently:
- Negative Sentiment: Zacks Research lowered its EPS estimates for Q1 2027 to $2.48 from $2.53, Q3 2027 to $2.17 from $2.23, and Q3 2028 to $3.85 from $4.06. The analyst firm maintained a Hold rating; the downward revisions may weigh on sentiment about Molina’s earnings outlook.
- Negative Sentiment: Three insiders reported selling a combined 10,382 shares for about $2.11 million, reducing their individual holdings by roughly 6% to 12%. These sales may be viewed as a negative signal, though insider transactions alone do not establish a change in the company’s fundamentals. Jeff Barlow SEC filing Richard Schapiro SEC filing Dale Wolf SEC filing
Institutional Investors Weigh In On Molina Healthcare
A number of hedge funds and other institutional investors have recently bought and sold shares of MOH. Fortitude Family Office LLC boosted its stake in Molina Healthcare by 63.7% in the third quarter. Fortitude Family Office LLC now owns 131 shares of the company’s stock worth $25,000 after purchasing an additional 51 shares in the last quarter. Elevation Wealth Partners LLC increased its stake in shares of Molina Healthcare by 118.2% in the second quarter. Elevation Wealth Partners LLC now owns 144 shares of the company’s stock valued at $33,000 after buying an additional 78 shares in the last quarter. Global Retirement Partners LLC acquired a new stake in shares of Molina Healthcare in the second quarter valued at $39,000. Versant Capital Management Inc increased its stake in shares of Molina Healthcare by 341.6% in the second quarter. Versant Capital Management Inc now owns 340 shares of the company’s stock valued at $78,000 after buying an additional 263 shares in the last quarter. Finally, Contravisory Investment Management Inc. bought a new position in shares of Molina Healthcare in the second quarter valued at about $89,000. 98.50% of the stock is owned by institutional investors and hedge funds.
Wall Street Analysts Forecast Growth
MOH has been the topic of a number of analyst reports. Morgan Stanley upped their target price on shares of Molina Healthcare from $167.00 to $192.00 and gave the company an “equal weight” rating in a research note on Friday, October 23rd. Jefferies Financial Group restated a “hold” rating and set a $220.00 price target on shares of Molina Healthcare in a research note on Friday, October 23rd. Cantor Fitzgerald restated a “neutral” rating on shares of Molina Healthcare in a research note on Friday, October 9th. Robert W. Baird set a $198.00 price objective on Molina Healthcare in a report on Friday, October 23rd. Finally, Wells Fargo & Company decreased their price objective on Molina Healthcare from $235.00 to $220.00 and set an “equal weight” rating on the stock in a report on Tuesday, July 28th. Three analysts have rated the stock with a Buy rating, thirteen have given a Hold rating and two have issued a Sell rating to the company’s stock. According to data from MarketBeat, the company presently has a consensus rating of “Hold” and a consensus price target of $213.88.
View Our Latest Research Report on Molina Healthcare
About Molina Healthcare
Molina Healthcare, Inc. is a managed care company that provides health insurance plans primarily to people covered by government-sponsored programs. Its offerings include Medicaid plans, Medicare plans for eligible individuals and dual-eligible members, and health plans sold through government marketplaces under the Affordable Care Act. The company was founded in 1980 by physician C. David Molina in Long Beach, California, initially serving low-income families through community clinics. It later shifted its focus to providing managed health care, with Medicaid becoming a central part of its business.
Featured Articles
- Five stocks we like better than Molina Healthcare
- Intuitive Machines’ Business Is Taking Off—Will Its Stock Follow?
- The Next Big Thing May Not Be One Thing: Inside Lazard’s Megatrends ETF
- 3 Power and Grid Stocks That Could Keep Growing Even if AI Spending Slows
- Applied Materials Beats and Raises, But Investors Stay Unconvinced
Receive News & Ratings for Molina Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Molina Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
